Endometriosis Completed Phase 2 Trials for Danazol (DB01406)

Also known as: Sigmoid endometriosis / Endometriosis, unspecified / Endometriosis (morphologic abnormality) / Endometriosis (disorder) / Endometriosis, site unspecified

IndicationStatusPhase
DBCOND0001340 (Endometriosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03352076Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing LaparoscopyTreatment
NCT00758953Pain Associated With EndometriosisTreatment